Both in Pharmaceuticals
Royalty Pharma vs United Therapeutics
Over the past year RPRX returned +79.0% and UTHR returned +34.4%; their daily moves had a correlation of 0.21.
RPRX +79.0% UTHR +34.4%Growth of $1, one year, split-adjusted
| Metric | RPRX | UTHR |
|---|---|---|
| Price | $67.18 | $598.72 |
| Market cap | $29.91B | $25.68B |
| Today | +1.90% | +0.87% |
| 1 month | +16.6% | +4.8% |
| 6 months | +35.8% | +5.0% |
| Year to date | +73.9% | +22.9% |
| 1 year | +83.2% | +31.5% |
| Revenue growth (YoY) | +16.5% | −1.9% |
| Gross margin | 100.0% | 87.3% |
| Net margin | 2.7% | 42.5% |
| P/E (TTM) | 36.7× | 19.6× |
| Price / sales | 11.8× | 8.1× |
| Net cash | -$8.23B | $2.66B |
| Dividend yield | 1.40% | — |
| Volatility (60d) | 24.9% | 37.7% |
| Short % of float | 2.9% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).